Compared with rituximab plus CHOP, CHOP-radioimmunotherapy demonstrated superior 15-year PFS (47 vs 34%). HealthDay News — For patients with untreated, advanced-stage follicular lymphoma (FL), ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...
New plans are underway to transform the community surrounding the Ravenswood Generating Station in Long Island City, Queens. It comes alongside efforts to turn the natural gas power plant into a ...
Key Takeaways Entrepreneur tested out AI architecture expert bot Vitruvius, which is currently in beta and available for free. The bot takes a prompt and transforms it into a floor plan. The long-term ...
Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results